- Home
- CBNK vs ESPR Comparison
CBNK vs ESPR Comparison
Compare CBNK & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- ESPR
- Stock Information
- Founded
- CBNK 1974
- ESPR 2008
- Country
- CBNK United States
- ESPR United States
- Employees
- CBNK N/A
- ESPR N/A
- Industry
- CBNK Major Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- CBNK Finance
- ESPR Health Care
- Exchange
- CBNK Nasdaq
- ESPR Nasdaq
- Market Cap
- CBNK 462.4M
- ESPR 410.2M
- IPO Year
- CBNK 2018
- ESPR 2013
- Fundamental
- Price
- CBNK $29.07
- ESPR $2.21
- Analyst Decision
- CBNK Hold
- ESPR Buy
- Analyst Count
- CBNK 1
- ESPR 5
- Target Price
- CBNK $32.00
- ESPR $5.13
- AVG Volume (30 Days)
- CBNK 59.7K
- ESPR 4.6M
- Earning Date
- CBNK 01-28-2025
- ESPR 02-25-2025
- Dividend Yield
- CBNK 1.38%
- ESPR N/A
- EPS Growth
- CBNK N/A
- ESPR N/A
- EPS
- CBNK 2.33
- ESPR N/A
- Revenue
- CBNK $157,884,000.00
- ESPR $295,451,000.00
- Revenue This Year
- CBNK N/A
- ESPR $186.88
- Revenue Next Year
- CBNK $28.67
- ESPR $22.46
- P/E Ratio
- CBNK $12.45
- ESPR N/A
- Revenue Growth
- CBNK 0.41
- ESPR 187.12
- 52 Week Low
- CBNK $19.02
- ESPR $1.58
- 52 Week High
- CBNK $31.22
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- CBNK 57.32
- ESPR 44.94
- Support Level
- CBNK $26.49
- ESPR $2.05
- Resistance Level
- CBNK $28.28
- ESPR $2.40
- Average True Range (ATR)
- CBNK 0.62
- ESPR 0.14
- MACD
- CBNK 0.05
- ESPR 0.01
- Stochastic Oscillator
- CBNK 100.00
- ESPR 45.71
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, Corporate Office, and OpenSky. Its Commercial Banking division offers banking-related services to clients, Capital Bank Home Loans division offers conventional and government-guaranteed residential mortgage loans on a nationwide basis for sale into the secondary market, while its OpenSky division provides secured credit cards on a nationwide basis to under-banked populations and those looking to rebuild their credit scores.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.